Results 161 to 170 of about 47,328 (256)

Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer. [PDF]

Transl Cancer Res
Sun W, Guo H, Cai M, Ma G, Zhang L, Yu Y, Zhan H.   +6 more
europepmc   +1 more source

THE SYNTHESIS OF CYTIDINE DIPHOSPHATE CHOLINE, CYTIDINE DIPHOSPHATE ETHANOLAMINE, AND RELATED COMPOUNDS

Journal of Biological Chemistry, 1956
openaire   +2 more sources

The power of many: when genetics met yeasts and high‐throughput

Biological Reviews, Volume 101, Issue 4, Page 1662-1682, August 2026.
ABSTRACT In recent years, complex technological capabilities have evolved, driven by the need to solve complex and integrative biological questions through global analyses. New equipment allows the scaling up and automation of processes which previously were carried out on a very limited scale.
Víctor A. Tallada, Víctor Carranco
wiley   +1 more source

Clickable RNA via 4'-<i>C</i>-Ethynyl Cytidine─A Novel Design for Metabolically Stable Guide RNAs in RNA Editing. [PDF]

Bioconjug Chem
Bereiter R, Manjunath A, Beal PA.
europepmc   +1 more source

TET2 as a Context‐Dependent Epigenetic Integrator in Clonal Hematopoiesis, Inflammation, Cancer, and Immunotherapy

Cell Biochemistry and Function, Volume 44, Issue 8, August 2026.
ABSTRACT Ten‐Eleven Translocation 2 (TET2) is an Fe(II)‐ and α‐ketoglutarate‐dependent dioxygenase that initiates active DNA demethylation by oxidizing 5‐methylcytosine (5mC). Beyond this enzymatic role, TET2 links DNA methylation dynamics with chromatin regulation, cellular metabolism, immune‐cell identity, and treatment response in a context ...
XiaoJie Liu, Jiangchen Liu, Liu Feng, Dan Xu, Xianling Wei, Dekuai Tong   +5 more
wiley   +1 more source

Cytosolic DNA inhibits rDNA transcription by retaining the RNA polymerase I transcription machinery. [PDF]

EMBO J
Xu Y, Wang Q, Qian C, Lu S, He Z, Liu W, Wan W.   +6 more
europepmc   +1 more source

Safety, Tolerability, Pharmacokinetics, Food Effect of Ribitol, and Its Effect on QTcF in Healthy Adults: First‐in‐Human, Randomized, Double‐Blind (Sponsor Unblinded), Placebo‐Controlled Studies

Clinical Pharmacology in Drug Development, Volume 15, Issue 8, August 2026.
Abstract Limb‐girdle muscle dystrophy Type R9 (LGMDR9), also known as LGMD Type 2I, is a rare genetic disease caused by partial loss of function of fukutin‐related protein (FKRP) enzyme which glycosylates alpha‐dystroglycan, thereby stabilizing myocytes during contraction.
Daniel D. Gretler, Athiwat Hutchaleelaha, Uma Sinha, Kristen Rickert, Doug Sproule   +4 more
wiley   +1 more source

Gene expression in immune cells infected with Orientia tsutsugamushi and the antigenic variability of 56-kDa type-specific antigen. [PDF]

Sci Rep
So-In C, Sunthamala P, Chopjitt P, Kerdsin A, Khankhum S, Sunthamala N.   +5 more
europepmc   +1 more source

2'‐O‐Acetal Levulinic Ester Ribonucleoside 3'‐Phosphoramidites for the Solid‐Phase Synthesis of Long RNA

Current Protocols, Volume 6, Issue 8, August 2026.
Abstract Solid‐phase RNA synthesis is challenging because the 2'‐hydroxyl requires a protecting group that is stable during chain assembly yet easily removable without degrading the product. Driven by the demand for long RNA therapeutics, we report a synthesis method using 2'‐O‐acetal levulinic ester (ALE) ribonucleoside 3'‐O‐phosphoramidites.
Zidi Lyu, Adam Katolik, Masad J. Damha
wiley   +1 more source

Author Correction: Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice. [PDF]

Nat Commun
Soudais C, Schaus R, Bachelet C, Minet N, Mouasni S, Garcin C, Souza CL, David P, Cousu C, Asnagli H, Parker A, Palmquist-Gomes P, Sepulveda FE, Storck S, Meilhac SM, Fischer A, Martin E, Latour S.   +17 more
europepmc   +1 more source